AZD9833
Drug timelines are a Plus or Pro feature.
8 regulatory and trial events tracked for AZD9833, covering 2023-12-12 to 2026-04-21. Get the full timeline:
Most recent: Clinical Trial Update: Phase III Study to Assess AZD9833+ CDK4/6 Inhibitor in HR+/HER2-MBC With Detectable ESR1m Before Progression (SERENA-6) [Phase 3]